Skip to content

Intraperitoneal Application of Levobupivacaine During Laparoscopic Surgery in Kids.

Intraperitoneal Instillation of Levobupivacaine in Laparoscopic Pediatric Procedures

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02037711
Enrollment
40
Registered
2014-01-16
Start date
2013-05-31
Completion date
2013-11-30
Last updated
2016-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Laparoscopic, Levobupivacaine, Pediatric, Anesthesia, Instillation, surgeries

Brief summary

Pain after laparoscopic surgery has been associated with surgical manipulations, including intraperitoneal insufflation of carbon dioxide (CO2), resulting in peritoneal stretching, diaphragmatic irritation, changes in intra-abdominal pH, and retention of the insufflated gas in the abdominal cavity after surgery. These effects may result in the irritation of peritoneal nerves causing visceral pain, as commonly reported after laparoscopic procedures in pediatrics. The study hypothesis is that Intraperitoneal local anesthetic (levobupivacaine) instillation can provide pain relief after laparoscopic surgery, but local anesthetic distribution may not always be uniform throughout the peritoneal surface. Many methods were tried for intraperitoneal application of local anesthetics in laparoscopic surgery such as local anesthetic (LA) instillation and LA nebulization. -But these methods are not widely used in pediatrics upon our knowledge

Interventions

Group I (Chirocaine group) (n=20): Levobupivacaine 0.5% will be instilled during insufflations of CO2 at the beginning of surgery at a dose of 2mg/kg.

DRUGNormal saline

Group II (control group) (n=20): laparoscopy done with instillation of normal saline instead of levobupivacain

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patient undergoing laparoscopic surgeries 2. Pediatric weighing 4 kg or more 3. Patients with free medical history

Exclusion criteria

1. Parents refusal 2. Known allergy to levobupivacaine 3. Acute preoperative pain other than biliary colic 4. chronic pain treatment or antiepileptic therapy 5. Severe hepatic or renal impairment 6. Cognitive impairment or communication problems.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain scoring (CHEOPS)up to six hourspain score will be assessed immediately postoperative, then after 1 hour, 2 hours, and 6 hours.

Secondary

MeasureTime frameDescription
changes in Haemodynamics including ( Heart Rate)during the period of the operation (Preoperative, post-induction, after instillation of levobupivacaine or saline, postoperative for 6 hours at 0-1-2-6Represented as mean and standard deviation, hemodynamic variables will be measured during the the surgery starting preoperatively, following induction of anesthesia, during the procedure and postoperatively (6 hours postoperative)
changes in Haemodynamics including ( Non Invasive Blood Pressure)during the period of the operation (Preoperative, post-induction, after instillation of levobupivacaine or saline, postoperative for 6 hours at 0-1-2- 6Represented as mean and standard deviation, hemodynamic variables will be measured during the the surgery starting preoperatively, following induction of anesthesia, during the procedure and postoperatively (6 hours postoperative)

Other

MeasureTime frame
Indirect signs of local anaesthetic toxicity (intraoperative arrhythmias and delayed awakening)From time of instillation of levobupivacaine till 6 hours postoperative.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026